MSLN, a glycoprotein on the cell surface, is overexpressed in many cancers and is relevant to novel anti-cancer treatment by regulating the tumor microenvironment (Hilliard, 2018; Cerise et al., 2019). The gene discussed is MSLN; the disease is cancer.